Sort
82,697 grants matching “vaccine development”
Transdermal Naltrexone for Opiate Addiction and Alcoholism
$695,993Audra L Stinchcomb · Alltranz, Inc. · R42 · FY2014 · DA
Impact of School-Based Health Centers on Improving Health and Promoting Equity
$695,988Ashley Kranz · Rand Corporation · R01 · FY2023 · HD
Capsular serotype in group B Streptococcus colonization and disease
$695,959Adam Jonathan Ratner · New York University School Of Medicine · R01 · FY2024 · AI
Capsular serotype in group B Streptococcus colonization and disease
$695,959Adam Jonathan Ratner · New York University School Of Medicine · R01 · FY2025 · AI
Metapneumovirus Biology and Vaccine Development
$695,904Peter Leon Collins · Niaid Extramural Activities · Z01 · FY2007 · AI
GENERATION/EMERGENCE OF VARIANT IN HEPADNAVIRUS INFECTON
$695,900University Of New Mexico · R01 · FY2004 · CA
Non-human primate core
$695,898Karen A Norris · Lsu Health Sciences Center · P01 · FY2011 · HL
A mechanistic understanding of tuberculosis progression through bacterial reporter strains
$695,858David G Russell · Cornell University · R01 · FY2019 · AI
Multiscale modeling of influenza vaccination strategies for optimal T cell immunity
$695,821Jacob E Kohlmeier · Emory University · U01 · FY2020 · HL
Mechanism and Inhibition of Thogotovirus Entry
$695,774Adrianus Cm Boon · Washington University · R01 · FY2023 · AI
Resource for Nonhuman Primate Cell Depleting Antibodies
$695,728Keith A Reimann · Beth Israel Deaconess Medical Center · R24 · FY2011 · RR
Resource for Nonhuman Primate Cell Depleting Antibodies
$695,727Keith A Reimann · Beth Israel Deaconess Medical Center · R24 · FY2012 · OD
Microneedle-based immunization against pandemic influenza
$695,719Mark R Prausnitz · Georgia Institute Of Technology · R01 · FY2008 · EB
The Pathogenesis of Enteric Fever
$695,708Ferric C Fang · University Of Washington · R01 · FY2023 · AI
The Pathogenesis of Enteric Fever
$695,708Ferric C Fang · University Of Washington · R01 · FY2022 · AI
Innate Control of SIV-Specific Adaptive Immunity
$695,698Bali Pulendran · Emory University · U19 · FY2014 · AI
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts
$695,679Timothy R Sterling · Vanderbilt University Medical Center · R01 · FY2021 · AI
Mechanisms controlling the persistence of infectious HIV reservoirs in children
$695,642Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2018 · HD
Mechanistic studies of BLyS-mediated modulation in HIV-1 Env-specific antibody responses
$695,610Michael Paul Cancro · University Of Pennsylvania · R01 · FY2016 · AI
Immunogen design and testing
$695,598Barton F Haynes · University Of Pennsylvania · P01 · FY2018 · AI
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions
$695,569Harel Dahari · Loyola University Chicago · R01 · FY2024 · AI
COVID-19 Supplement: Systems Immune Profiling of Divergent Responses to Infection
$695,543David A. Hafler · Yale University · U19 · FY2020 · AI
Core D: Clinical Recruitment
$695,543Albert C Shaw · Yale University · U19 · FY2020 · AI
MEMBRANE BASED ROLLER BOTTLE
$695,500Wilson Wolf Manufacturing Corporation · R44 · FY2004 · HL
Plasmodium vivax Erythrocyte Invasion Mechanisms and Humoral Immune Response in Duffy Negative Africans
$695,482Eugenia Lo · Drexel University · R01 · FY2024 · AI